Companion Animal In-clinic Diagnostic Reagents and Consumables Market Report – Research, Industry Analysis Reports and Market Demands

Global Companion Animal In-clinic Diagnostic Reagents and Consumables Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

2 Company Profiles

3 Market Competition, by Players

3.1 Global Companion Animal In-clinic Diagnostic Reagents and Consumables Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Companion Animal In-clinic Diagnostic Reagents and Consumables by Company Revenue
- 3.2.2 Top 3 Companion Animal In-clinic Diagnostic Reagents and Consumables Players Market Share in 2025
- 3.2.3 Top 6 Companion Animal In-clinic Diagnostic Reagents and Consumables Players Market Share in 2025
3.3 Companion Animal In-clinic Diagnostic Reagents and Consumables Market: Overall Company Footprint Analysis
- 3.3.1 Companion Animal In-clinic Diagnostic Reagents and Consumables Market: Region Footprint
- 3.3.2 Companion Animal In-clinic Diagnostic Reagents and Consumables Market: Company Product Type Footprint
- 3.3.3 Companion Animal In-clinic Diagnostic Reagents and Consumables Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

4.1 Global Companion Animal In-clinic Diagnostic Reagents and Consumables Consumption Value and Market Share by Type (2021-2026)
4.2 Global Companion Animal In-clinic Diagnostic Reagents and Consumables Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

5.1 Global Companion Animal In-clinic Diagnostic Reagents and Consumables Consumption Value Market Share by Application (2021-2026)
5.2 Global Companion Animal In-clinic Diagnostic Reagents and Consumables Market Forecast by Application (2027-2032)

6 North America

6.1 North America Companion Animal In-clinic Diagnostic Reagents and Consumables Consumption Value by Type (2021-2032)
6.2 North America Companion Animal In-clinic Diagnostic Reagents and Consumables Market Size by Application (2021-2032)
6.3 North America Companion Animal In-clinic Diagnostic Reagents and Consumables Market Size by Country
- 6.3.1 North America Companion Animal In-clinic Diagnostic Reagents and Consumables Consumption Value by Country (2021-2032)
- 6.3.2 United States Companion Animal In-clinic Diagnostic Reagents and Consumables Market Size and Forecast (2021-2032)
- 6.3.3 Canada Companion Animal In-clinic Diagnostic Reagents and Consumables Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Companion Animal In-clinic Diagnostic Reagents and Consumables Market Size and Forecast (2021-2032)

7 Europe

7.1 Europe Companion Animal In-clinic Diagnostic Reagents and Consumables Consumption Value by Type (2021-2032)
7.2 Europe Companion Animal In-clinic Diagnostic Reagents and Consumables Consumption Value by Application (2021-2032)
7.3 Europe Companion Animal In-clinic Diagnostic Reagents and Consumables Market Size by Country
- 7.3.1 Europe Companion Animal In-clinic Diagnostic Reagents and Consumables Consumption Value by Country (2021-2032)
- 7.3.2 Germany Companion Animal In-clinic Diagnostic Reagents and Consumables Market Size and Forecast (2021-2032)
- 7.3.3 France Companion Animal In-clinic Diagnostic Reagents and Consumables Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Companion Animal In-clinic Diagnostic Reagents and Consumables Market Size and Forecast (2021-2032)
- 7.3.5 Russia Companion Animal In-clinic Diagnostic Reagents and Consumables Market Size and Forecast (2021-2032)
- 7.3.6 Italy Companion Animal In-clinic Diagnostic Reagents and Consumables Market Size and Forecast (2021-2032)

8 Asia-Pacific

8.1 Asia-Pacific Companion Animal In-clinic Diagnostic Reagents and Consumables Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Companion Animal In-clinic Diagnostic Reagents and Consumables Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Companion Animal In-clinic Diagnostic Reagents and Consumables Market Size by Region
- 8.3.1 Asia-Pacific Companion Animal In-clinic Diagnostic Reagents and Consumables Consumption Value by Region (2021-2032)
- 8.3.2 China Companion Animal In-clinic Diagnostic Reagents and Consumables Market Size and Forecast (2021-2032)
- 8.3.3 Japan Companion Animal In-clinic Diagnostic Reagents and Consumables Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Companion Animal In-clinic Diagnostic Reagents and Consumables Market Size and Forecast (2021-2032)
- 8.3.5 India Companion Animal In-clinic Diagnostic Reagents and Consumables Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Companion Animal In-clinic Diagnostic Reagents and Consumables Market Size and Forecast (2021-2032)
- 8.3.7 Australia Companion Animal In-clinic Diagnostic Reagents and Consumables Market Size and Forecast (2021-2032)

9 South America

9.1 South America Companion Animal In-clinic Diagnostic Reagents and Consumables Consumption Value by Type (2021-2032)
9.2 South America Companion Animal In-clinic Diagnostic Reagents and Consumables Consumption Value by Application (2021-2032)
9.3 South America Companion Animal In-clinic Diagnostic Reagents and Consumables Market Size by Country
- 9.3.1 South America Companion Animal In-clinic Diagnostic Reagents and Consumables Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Companion Animal In-clinic Diagnostic Reagents and Consumables Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Companion Animal In-clinic Diagnostic Reagents and Consumables Market Size and Forecast (2021-2032)

10 Middle East & Africa

10.1 Middle East & Africa Companion Animal In-clinic Diagnostic Reagents and Consumables Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Companion Animal In-clinic Diagnostic Reagents and Consumables Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Companion Animal In-clinic Diagnostic Reagents and Consumables Market Size by Country
- 10.3.1 Middle East & Africa Companion Animal In-clinic Diagnostic Reagents and Consumables Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Companion Animal In-clinic Diagnostic Reagents and Consumables Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Companion Animal In-clinic Diagnostic Reagents and Consumables Market Size and Forecast (2021-2032)
- 10.3.4 UAE Companion Animal In-clinic Diagnostic Reagents and Consumables Market Size and Forecast (2021-2032)

11 Market Dynamics

11.1 Companion Animal In-clinic Diagnostic Reagents and Consumables Market Drivers
11.2 Companion Animal In-clinic Diagnostic Reagents and Consumables Market Restraints
11.3 Companion Animal In-clinic Diagnostic Reagents and Consumables Trends Analysis
11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

12.1 Companion Animal In-clinic Diagnostic Reagents and Consumables Industry Chain
12.2 Companion Animal In-clinic Diagnostic Reagents and Consumables Upstream Analysis
12.3 Companion Animal In-clinic Diagnostic Reagents and Consumables Midstream Analysis
12.4 Companion Animal In-clinic Diagnostic Reagents and Consumables Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology
14.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Companion Animal In-clinic Diagnostic Reagents and Consumables market size was valued at US$ 803 million in 2025 and is forecast to a readjusted size of US$ 1466 million by 2032 with a CAGR of 9.0% during review period.
In 2025, global shipments of Companion Animal In-clinic Diagnostic Reagents and Consumables reached approximately 102.6 M Units, with an average selling price of around US$7.60/Unit. Companion animal in-clinic diagnostic reagents and consumables refer to consumable in-vitro diagnostic products used in veterinary hospitals, pet clinics, and small-animal clinical settings for disease screening, health assessment, organ function testing, infectious disease detection, endocrine testing, acute-care biomarker testing, and transfusion compatibility evaluation in companion animals, primarily dogs and cats. These products mainly include standalone rapid test kits, analyzer-bound reagents and consumables, immunoassay strips, chemistry reagent discs, dry chemistry slides, molecular diagnostic cartridges, blood typing cards, crossmatching cards, quality controls, calibrators, and cleaning solutions. They are commonly based on lateral flow assays, fluorescence immunoassay, chemiluminescence immunoassay, dry and wet chemistry, microfluidics, hematology analysis, coagulation testing, and nucleic acid amplification technologies, enabling veterinarians to conduct rapid or near-patient testing for diagnosis, treatment selection, preoperative assessment, chronic disease monitoring, and follow-up care.
Market growth is mainly driven by rising pet healthcare spending, broader adoption of in-clinic testing in veterinary practices, and increasing demand for chronic disease monitoring and rapid clinical decision-making. Compared with outsourced laboratory testing, in-clinic diagnostics allow veterinarians to perform faster infectious disease screening, preoperative assessment, acute-care evaluation, and treatment follow-up at the point of care.
From a product structure perspective, analyzer-bound reagents and consumables represent a key value driver, including chemistry reagent discs, dry chemistry slides, immunoassay strips, hematology reagents, molecular cartridges, controls, calibrators, and cleaning consumables. Standalone rapid test kits remain an essential product category, especially for high-frequency infectious and parasitic disease testing such as canine parvovirus, canine distemper, feline panleukopenia, FeLV/FIV, and heartworm. As veterinary clinics place greater emphasis on diagnostic accuracy, turnaround time, and workflow efficiency, fluorescence immunoassay, chemiluminescence immunoassay, microfluidic chemistry, and molecular POCT products are expected to gain further share.
From a competitive standpoint, the market is shaped by global veterinary diagnostics leaders, specialized rapid test manufacturers, analyzer platform suppliers, and Chinese POCT/OEM companies. Leading players benefit from installed analyzer bases, broad test menus, strong brand recognition, distribution channels, and recurring consumables demand. Chinese suppliers are becoming more active in rapid test kits, molecular POCT, microfluidic reagent discs, and analyzer-bound consumables. Going forward, competition is likely to shift from single-product pricing toward integrated capabilities across testing platforms, assay menus, reagent supply stability, and clinical workflow support.
This report is a detailed and comprehensive analysis for global Companion Animal In-clinic Diagnostic Reagents and Consumables market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Companion Animal In-clinic Diagnostic Reagents and Consumables market size and forecasts, in consumption value ($ Million), 2021-2032
Global Companion Animal In-clinic Diagnostic Reagents and Consumables market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Companion Animal In-clinic Diagnostic Reagents and Consumables market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Companion Animal In-clinic Diagnostic Reagents and Consumables market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Companion Animal In-clinic Diagnostic Reagents and Consumables
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Companion Animal In-clinic Diagnostic Reagents and Consumables market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include IDEXX Laboratories, Inc., Zoetis Inc., Mars, Incorporated, DMS Laboratories, Inc., Nova Biomedical Corporation, DiaSys Diagnostic Systems GmbH, Virbac, Fassisi GmbH, MegaCor Diagnostik GmbH, Biogal Galed Labs, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Companion Animal In-clinic Diagnostic Reagents and Consumables market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Analyzer-bound Reagents and Consumables
General Standalone Rapid Test Kits
Specialty Manual and Semi-manual Diagnostic Consumables
Other
Market segment by Technology Platforms
Lateral Flow Rapid Assays
Instrument-based Immunoassays
Clinical Chemistry and Electrochemical Analysis
Cell Counting and Coagulation Measurement
Nucleic Acid Amplification Testing, NAAT
Other Technology Platforms
Market segment by Application
Infectious and Parasitic Disease Testing
Routine Health Screening and Organ Function Testing
Endocrine, Metabolic and Reproductive Testing
Acute Care and Specialty Biomarker Testing
Transfusion and Blood Compatibility Testing
Other Companion Animal In-clinic Testing
Market segment by players, this report covers
IDEXX Laboratories, Inc.
Zoetis Inc.
Mars, Incorporated
DMS Laboratories, Inc.
Nova Biomedical Corporation
DiaSys Diagnostic Systems GmbH
Virbac
Fassisi GmbH
MegaCor Diagnostik GmbH
Biogal Galed Labs
Alvedia
EUROLyser Diagnostica GmbH
Innovative Diagnostics SAS
Bio-X Diagnostics S.A.
Vitrosens Biotechnology
Gold Standard Diagnostics
J&G Biotech Ltd
Randox Laboratories Ltd.
Diatron MI Zrt.
bioMérieux SA
FUJIFILM Corporation
ARKRAY, Inc.
Bionote, Inc.
VetAll Laboratories
IMEDICOM Co., Ltd.
Median Diagnostics Inc.
Hysen Biotech Inc.
KH Medical Co., Ltd.
Ubio Biotechnology Systems Pvt. Ltd.
Bioguard Corporation
GeneReach Biotechnology Corp.
Mindray Bio-Medical Electronics Co., Ltd.
Guangzhou Wondfo Biotech Co., Ltd.
Getein Biotech, Inc.
Genrui Biotech Inc.
Chengdu Seamaty Technology Co., Ltd.
Shenzhen Dymind Biotechnology Co., Ltd.
Tianjin LOCMEDT Technology Co., Ltd.
Coyote Bioscience Co., Ltd.
Beijing Nabai Biotechnology Co., Ltd.
Nanjing Poclight Biotechnology Co., Ltd.
Hangzhou Biotest Biotech Co., Ltd.
Hangzhou AllTest Biotech Co., Ltd.
Assure Tech (Hangzhou) Co., Ltd.
Hangzhou Evegen Biotech Co., Ltd.
Hangzhou Frenovo Biotech Co., Ltd.
Ring Biotechnology Co., Ltd.
Zhejiang Pushkang Biotechnology Co., Ltd.
Hangzhou NewTest Biotech Co., Ltd.
Hunan Shengwei Dongmu Biotechnology Development Co., Ltd.
Zhejiang Yizai Medical Technology Co., Ltd.
Jinan Babio Biotechnology Co., Ltd.
Hangzhou LifeReal Biotechnology Co., Ltd.
Xiamen Medara Biotechnology Co., Ltd.
Hunan Guanmu Biotechnology Co., Ltd.
GENERADAR (Xiamen) Biotech Co., Ltd.
Xiamen Kangcui Biotechnology Co., Ltd.
Shanghai S&C Biotech Co., Ltd.
Shenzhen Bioeasy Biotechnology, Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Companion Animal In-clinic Diagnostic Reagents and Consumables product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Companion Animal In-clinic Diagnostic Reagents and Consumables, with revenue, gross margin, and global market share of Companion Animal In-clinic Diagnostic Reagents and Consumables from 2021 to 2026.
Chapter 3, the Companion Animal In-clinic Diagnostic Reagents and Consumables competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Companion Animal In-clinic Diagnostic Reagents and Consumables market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Companion Animal In-clinic Diagnostic Reagents and Consumables.
Chapter 13, to describe Companion Animal In-clinic Diagnostic Reagents and Consumables research findings and conclusion.

Buy now